COVID‑19 vaccination in liver transplant recipients
A Gkoufa, M Saridaki… - Experimental and …, 2023 - spandidos-publications.com
Severe acute respiratory syndrome coronavirus 2 (Sars‑CoV‑2) infection has significantly
affected immunocompromised individuals and subsequently, liver transplant recipients …
affected immunocompromised individuals and subsequently, liver transplant recipients …
[HTML][HTML] The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review
Introduction This study examines the efficacy and safety of three COVID-19 booster vaccines
including mRNA-based vaccines (BNT162b2 (BioNTech/Pfizer) and/or mRNA-1273 …
including mRNA-based vaccines (BNT162b2 (BioNTech/Pfizer) and/or mRNA-1273 …
Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient
J Long, M Soni, P Muranski, MJ Miller… - Frontiers in …, 2023 - frontiersin.org
We present a case report of a 63-year-old female health care worker who is 15 years status
post double lung transplant and six years status post living related donor kidney transplant …
post double lung transplant and six years status post living related donor kidney transplant …
A Meta-Analysis on the Association between Peptic Ulcer Disease and COVID-19 Severity
Y Wang, J Xu, L Shi, H Yang, Y Wang - Vaccines, 2023 - mdpi.com
The association between peptic ulcer disease and the severity of coronavirus disease 2019
(COVID-19) is inconclusive across individual studies. Thus, this study aimed to investigate …
(COVID-19) is inconclusive across individual studies. Thus, this study aimed to investigate …